Profile
TAK ZTS HLN TEVA VTRS NBIX
Company Name Takeda Pharmaceutical Company Limited Zoetis Inc. Haleon plc Teva Pharmaceutical Industries Limited Viatris Inc. Neurocrine Biosciences, Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic
Market Cap $56.52B $56.15B $49.48B $39.78B $14.94B $14.08B
Employees 49.28K 13.80K 24.56K 37.00K 32.00K 1.80K
CEO Christophe Weber Kristin C. Peck Brian James McNamara Richard D. Francis Scott Andrew Smith Kyle W. Gano
Ratings
TAK ZTS HLN TEVA VTRS NBIX
Quant Rating Score 3 3 4 3 2 4
Quant Rating Neutral Neutral Buy Neutral Sell Buy
Trading
TAK ZTS HLN TEVA VTRS NBIX
Last Close $14.14 $118.8 $9.68 $24.59 $10.66 $143.56
High 52 $15.52 $178.71 $11.41 $25.83 $13.37 $154.8
Low 52 $12.89 $118.8 $8.73 $12.82 $7.26 $87.59
Price vs. 52 Week High -8.89 % -33.52 % -15.16 % -4.8 % -20.27 % -7.26 %
Price vs. 52 Week Low 9.7 % 0 % 10.88 % 91.81 % 46.83 % 63.9 %
Total Return
TAK ZTS HLN TEVA VTRS NBIX
1 Month Return 0.71 % -17.53 % 2.11 % 27.34 % 4.82 % 2.48 %
3 Month Return -6.73 % -21.96 % -0.05 % 36.16 % 0.28 % 7.83 %
6 Month Return 0.21 % -27.13 % -10.37 % 45.16 % 20.59 % 18.63 %
9 Month Return 1.73 % -24.08 % -3.1 % 48.4 % -1.84 % 25.96 %
YTD Return 6.8 % -27.09 % 1.47 % 11.57 % -14.38 % 5.17 %
1 Year Return 3.82 % -32.33 % 2.11 % 46.28 % -18.31 % 20.51 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
TAK ZTS HLN TEVA VTRS NBIX
Dividend Yield Percentage (TTM) 3.6 % 1.59 % 1.41 % - 3.7 % -
Dividend Paid and Capex Coverage Ration (TTM) 2.23 % 1.89 % 2.01 % 4 % 2.09 % 14.57 %
Dividend Per Share (TTM) 198 % 2.03 % 0.06 % - 0.48 % -
Payout Ratio (TTM) 277.04 % 32.55 % 27.27 % - -15.34 % -
Profitability
TAK ZTS HLN TEVA VTRS NBIX
Gross Profit Margin TTM 59.49 % 70.63 % 61.81 % 51.76 % 36.07 % 98.37 %
Return on Assets TTM 0.73 % 17.49 % 4.78 % 3.48 % -9.73 % 10.03 %
Return on Equity TTM 1.58 % 53.56 % 9.4 % 20.09 % -22.69 % 15.82 %
Return on Capital Employed TTM 3.59 % 26.48 % 8.34 % 11.54 % -8.43 % 15.17 %
Net Income Per EBT TTM 54.99 % 79.59 % 76.52 % 114.62 % 95.92 % 68.09 %
EBT Per Ebit TTM 44.75 % 94.2 % 88.09 % 39.3 % 149.32 % 114.25 %
EBIT Per Revenue TTM 10.28 % 37.63 % 20.49 % 18.15 % -18.25 % 20.51 %
Cash Flow To Debt Ratio TTM 23.13 % 40.09 % 12.02 % 11.62 % 13.47 % 148.65 %
Receivables Turnover TTM 5.89 6.1 5.14 4.68 3.94 3.69
Payables Turnover TTM 3.87 6.73 1.18 3.31 6.81 0.37
Inventory Turnover TTM 1.29 1.12 3.72 2.63 2.2 0.63
Fixed Asset Turnover TTM 214.23 % 241.44 % 589.57 % 392.13 % 488.38 % 473.81 %
Asset Turnover TTM 28.97 % 61.99 % 34.62 % 42.58 % 37.25 % 62.89 %
Operating Cash Flow Per Share TTM 710.55 6.58 0.11 1.76 1.7 6.41
Free Cash Flow Per Share TTM 589.53 5.06 0.1 1.32 1.37 5.97
Cash Per Share TTM 48236.45 % 470.54 % 7.46 % 309.55 % 99.36 % 1121.53 %
Operating Cash Flow Sales Ratio TTM 25.14 % 31.03 % 9.32 % 11.64 % 14.04 % 23.74 %
Free Cash Flow Operating Cash Flow Ratio TTM 82.97 % 76.82 % 90.65 % 74.99 % 80.65 % 93.14 %
Cash Flow Coverage Ratios TTM 23.13 % 40.09 % 12.02 % 11.62 % 13.47 % 148.65 %
Price To Free Cash Flows Ratio TTM 9.34 25.07 38.08 25.95 9.34 23.74
Price To Operating Cash Flows Ratio TTM 7.75 19.35 35.1 19.5 7.62 22.04
Price Cash Flow Ratio TTM 7.75 19.35 35.1 19.5 7.62 22.04
Income Statement (TTM)
TAK ZTS HLN TEVA VTRS NBIX
Revenue $4581.55B $9.26B $11.23B $17.26B $14.74B $2.36B
Gross Profit $3001.33B $6.4B $6.95B $8.94B $5.62B $2.32B
Gross Profit Ratio 65.51% 69.1% 61.85% 51.79% 38.15% 98.56%
EBITDA $1210.51B $3.87B $2.51B $3.14B $2.82B $0.64B
Net Income $107.93B $2.49B $1.44B $1.41B $-0.63B $0.34B
EPS Diluted 33.62 5.47 0.32 1.2 -0.53 3.29
Balance Sheet (MRQ)
TAK ZTS HLN TEVA VTRS NBIX
Long Term Debt $3966.33B $5.39B $8.62B $15.56B $14.22B $0.46B
Total Liabilities $7312.37B $9.47B $18.09B $32.83B $22.87B $1.13B
Total Equity $6935.98B $4.77B $16.22B $7.91B $18.64B $2.59B
Total Investments $382.4B $0.03B $0.14B $0B $1.7B $1.71B
Total Debt $4515.27B $6.74B $10.1B $17.38B $14.31B $0.46B
Total Assets $14248.34B $14.24B $34.32B $40.75B $41.5B $3.72B
Cash Flow Statement (TTM)
TAK ZTS HLN TEVA VTRS NBIX
Net Income $107.93B $2.5B $1.44B $1.42B $-0.63B $0.34B
Inventory $-34.97B $-0.04B $0.22B $0.15B $-0.72B $-0.02B
Dividends Paid $-302.5B $-0.79B $-0.57B $0B $-0.57B $0B
Operating Cash Flow $1057.18B $2.95B $2.3B $1.65B $2.3B $0.6B
Capital Expenditure $-200.8B $-0.66B $-0.25B $-0.5B $-0.33B $-0.04B
Related Stocks
Ticker Name Price
ACB Aurora Cannabis Inc. 3.59
ACOR Acorda Therapeutics, Inc. 0.661
ACRX AcelRx Pharmaceuticals, Inc. 0.86
ADMP Adamis Pharmaceuticals Corporation 0.775
ADMS Adamas Pharmaceuticals, Inc. 8.22
AERI Aerie Pharmaceuticals, Inc. 15.25
AGRX Agile Therapeutics, Inc. 1.51
AKAN Akanda Corp. 0.9396
ALIM Alimera Sciences, Inc. 5.54
ALVO Alvotech 5.15
ALVOW Alvotech 0.4508
AMPH Amphastar Pharmaceuticals, Inc. 28.63
AMRX Amneal Pharmaceuticals, Inc. 14.515
AMYT Amryt Pharma plc 14.7
ANIP ANI Pharmaceuticals, Inc. 80.35
APUS Apimeds Pharmaceuticals US, Inc 1.56
AQST Aquestive Therapeutics, Inc. 3.93
ASRT Assertio Holdings, Inc. 12.03
ATNX Athenex, Inc. 0.2031
AVDL Avadel Pharmaceuticals plc 21.62
ETFs With Exposure to TAK
Ticker ETF Name Weight Percentage Price
VEU Vanguard FTSE All-World ex-US Index Fund 0.002 80.16
FVD First Trust Value Line Dividend Index Fund 0.000001 48.945
CVY Invesco Zacks Multi-Asset Income ETF 0.432 28.765
GCOW Pacer Global Cash Cows Dividend ETF 0.74 45.95
AFTY Pacer CSOP FTSE China A50 ETF 0.27 16.2826
AGGY WisdomTree Yield Enhanced U.S. Aggregate Bond Fund 0.04 44.125
FPXI First Trust International Equity Opportunities ETF 2.11 66.905
ICOW Pacer Developed Markets International Cash Cows 100 ETF 1.77 42.68
PPH VanEck Pharmaceutical ETF 2.82 109.85
VETS Pacer Military Times Best Employers ETF 0.18 38.62
ACSG Xtrackers MSCI ACWI ex USA ESG Leaders Equity ETF 0.37 43.03
PTIN Pacer Trendpilot International ETF 0.18 34.625
VALT ETFMG Sit Ultra Short ETF 0.77 48.52
SLT Pacer Salt High truBeta US Market ETF 0.18 39.22
LSLT Pacer Salt Low truBeta US Market ETF 0.18 32
AVDE Avantis International Equity ETF 0.06 90.435
GERM ETFMG Treatments, Testing and Advancements ETF 0.89 19.1577
VIRS Pacer BioThreat Strategy ETF 0.18 40.025
FVL First Trust Value Line 100 Exchange-Traded Fund 0.000001 23.1559
SILX ETFMG Prime 2x Daily Junior Silver Miners ETF 0.73 1.75
RTL The Necessity Retail REIT, Inc. 0.27 7.61
BAD B.A.D. ETF 1.51 11.91
AVSD Avantis Responsible International Equity ETF 0.06 80.34
DFIC Dimensional International Core Equity 2 ETF 0.00097015 37.72
VFWAX Vanguard FTSE All-World ex-US Index Fd Admiral 0.002 49.11
IDVO Amplify International Enhanced Dividend Income ETF 1.32 43.055
DFAX Dimensional World ex U.S. Core Equity 2 ETF 0.00086684 36.04
TRPL Pacer Metaurus US Large Cap Dividend Multiplier 300 ETF 0.18 41.14
VEU.AX Vanguard All-World ex-US Shares Index ETF 0.002 112.65
GINX SGI Enhanced Global Income ETF 0.86 34.35
OZEM Roundhill GLP-1 & Weight Loss ETF 1.92 35.61
CGCV Capital Group Conservative Equi 0.1 31.66
ENDW Cambria Endowment Style ETF 0 33.0797
BDYN iShares Dynamic Equity Active ETF 0.05 26.47
AVTM American Century ETF Trust - Avantis Total Equity Markets ETF 0.01 50.44
Unlock